Clinical trial
Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)
NCT02211664 is registered in ClinicalTrials.gov with Flanders Medical Research Program as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)
- Lead sponsor
- Flanders Medical Research Program
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- March 31, 2018
- Enrollment
- 120 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral vascular disease